Drug information for SANCUSO
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
FILM, EXTENDED RELEASE; TRANSDERMAL
3.1MG/24HR
Prescription
(Reference Drug)
GRANISETRON
Granisetron
PROSTRAKAN INC
22198
2011-09-29 Label
2011-09-28 Letter
2009-09-30 Review
2008-09-19 Label
2008-09-16 Letter
Drug Adverse Effects information for SANCUSO
Role code
Indications
Reaction
# Reports
PS
NAUSEA
ABDOMINAL PAIN
1
PS
NAUSEA
BLOOD COUNT ABNORMAL
1
PS
NAUSEA
DEHYDRATION
1
PS
NAUSEA
DIARRHOEA
1
PS
NAUSEA
PRURITUS
1
PS
NAUSEA
RASH
1
PS
NAUSEA
RECTAL HAEMORRHAGE
1
PS
PROPHYLAXIS OF NAUSEA AND VOMITING
PRODUCT ADHESION ISSUE
4
PS
PROPHYLAXIS OF NAUSEA AND VOMITING
WRONG TECHNIQUE IN DRUG USAGE PROCESS
2
SS
PROPHYLAXIS OF NAUSEA AND VOMITING
PRODUCT ADHESION ISSUE
4
SS
PROPHYLAXIS OF NAUSEA AND VOMITING
WRONG TECHNIQUE IN DRUG USAGE PROCESS
2
C
ANXIETY
PLEURAL EFFUSION
2
C
CONSTIPATION
PLEURAL EFFUSION
4
C
NAUSEA
PLEURAL EFFUSION
6
C
PAIN
PLEURAL EFFUSION
4
C
RENAL CANCER
PLEURAL EFFUSION
3
Ads by Google